Toronto, Ontario–(Newsfile Corp. – February 11, 2021) – PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (“ PharmaDrug” or the “Company“), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines such as psychedelics, cannabis and naturally-derived approved drugs, is pleased to announce it has filed an application with the U.


Previous articleMindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds
Next articleProgressive Doctor Thinks Psychedelics May Be Used to Revive Comatose Patients